Summary
Elevance Health, Inc. (then WellPoint, Inc.) filed an 8-K on October 9, 2012, reporting the completion of a significant financing transaction. The company successfully issued and sold $1.5 billion in aggregate principal amount of 2.750% senior convertible debentures due 2042 to qualified institutional buyers. This offering, facilitated by Credit Suisse Securities, Merrill Lynch, and UBS Securities, raised approximately $1.47 billion in net proceeds after expenses. A portion of these proceeds, approximately $400 million, was immediately utilized to repurchase shares of the company's common stock, indicating a strategic move to manage shareholder equity and potentially boost earnings per share.
Key Highlights
- 1WellPoint, Inc. (now Elevance Health) raised $1.5 billion through the issuance of 2.750% senior convertible debentures due 2042.
- 2The offering was completed on October 9, 2012, to qualified institutional buyers via Rule 144A.
- 3Net proceeds from the offering were approximately $1.47 billion after deducting discounts and expenses.
- 4The company used approximately $400 million of the net proceeds to repurchase its common stock.
- 5The debentures are convertible into common stock at a conversion price of approximately $75.575 per share.
- 6The debentures have a maturity date of October 15, 2042, and bear interest semi-annually.
- 7Contingent interest provisions are included, triggered by specific trading price thresholds or extraordinary dividends.